Inventor · disambiguated record
Katrin Lorenz
Also filed as: LORENZ KATRIN
24 granted patents·5 pending applications·65 citations·filing 2009–2024
93Inventor score
Top patents by PatentIndex Score
29 records- 0190US9745360B2Dual GLP1/GIP or trigonal GLP1/GIP/glucagon agonistsSANOFI SA·Filed 2013·Granted Aug 29, 2017·14 cites·36 claims
- 0288US9750788B2Non-acylated exendin-4 peptide analoguesSANOFI SA·Filed 2014·Granted Sep 5, 2017·11 cites·23 claims
- 0381US9771406B2Peptidic dual GLP-1/glucagon receptor agonists derived from exendin-4SANOFI SA·Filed 2015·Granted Sep 26, 2017·4 cites·31 claims
- 0480US9789165B2Exendin-4 peptide analogues as dual GLP-1/GIP receptor agonistsSANOFI SA·Filed 2014·Granted Oct 17, 2017·4 cites·23 claims
- 0580US9751926B2Dual GLP-1/GIP receptor agonistsSANOFI SA·Filed 2014·Granted Sep 5, 2017·4 cites·27 claims
- 0680US9284333B2Fused pyrroledicarboxamides and their use as pharmaceuticalsSANOFI SA·Filed 2013·Granted Mar 15, 2016·5 cites·13 claims
- 0779US9127001B2Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-c]pyridines, their use as medicament, and pharmaceutical preparations comprising themBIALY LAURENT·Filed 2011·Granted Sep 8, 2015·6 cites·15 claims
- 0879US8742116B2Cycloalkylamine substituted isoquinolone derivativesPLETTENBURG OLIVER·Filed 2009·Granted Jun 3, 2014·4 cites·47 claims
- 0977US10538567B2Compounds as peptidic trigonal GLP1/glucagon/GIP receptor agonistsSANOFI SA·Filed 2017·Granted Jan 21, 2020·2 cites·38 claims
- 1077US10519211B2Compounds as peptidic GLP1/glucagon/GIP receptor agonistsSANOFI SA·Filed 2017·Granted Dec 31, 2019·2 cites·30 claims
- 1176US9982029B2Exendin-4 derivatives as selective peptidic dual GLP-1/glucagon receptor agonistsSANOFI SA·Filed 2016·Granted May 29, 2018·2 cites·34 claims
- 1276US9670261B2Functionalized exendin-4 derivativesSANOFI SA·Filed 2013·Granted Jun 6, 2017·2 cites·49 claims
- 1376US8541449B2Substituted isoquinolines and isoquinolinones as Rho kinase inhibitorsPLETTENBURG OLIVER·Filed 2009·Granted Sep 24, 2013·3 cites·50 claims
- 1471US2025115669A1FGFR1/KLB Targeting Agonistic Antigen-Binding Proteins and Conjugates Thereof with GLP-1R Agonistic PeptidesSANOFI SA·Filed 2024·Application pending·0 cites
- 1569US9884860B2Fused pyrroledicarboxamides and their use as pharmaceuticalsSANOFI SA·Filed 2016·Granted Feb 6, 2018·1 cites·15 claims
- 1668US8399482B26-substituted isoquinolines and isoquinolinonesPLETTENBURG OLIVER·Filed 2010·Granted Mar 19, 2013·1 cites·46 claims
- 1761US12054551B2FGFR1/KLB targeting agonistic antigen-binding proteins and conjugates thereof with GLP-1R agonistic peptidesSANOFI SA·Filed 2021·Granted Aug 6, 2024·0 cites·14 claims
- 1859US2024360194A1New Peptides as Potent and Selective GIP Receptor AgonistsSANOFI SA·Filed 2022·Application pending·0 cites
- 1954US10253079B2Functionalized Exendin-4 derivativesSANOFI SA·Filed 2017·Granted Apr 9, 2019·0 cites·30 claims
- 2051US8772492B2Substituted isoquinoline and isoquinolinone derivativesPLETTENBURG OLIVER·Filed 2009·Granted Jul 8, 2014·0 cites·48 claims
- 2151US2023103631A1Peptides as selective gip receptor agonistsSANOFI SA·Filed 2021·Application pending·0 cites
- 2250US8524737B2Bi- and polycyclic substituted isoquinoline and isoquinolinone derivativesPLETTENBURG OLIVER·Filed 2009·Granted Sep 3, 2013·0 cites·37 claims
- 2350US2023127047A1Selective gip receptor agonists comprising a chelating moiety for imaging and therapy purposesANTAROS MEDICAL AB·Filed 2021·Application pending·0 cites
- 2449US8710077B2Cycloalkylamine substituted isoquinoline and isoquinolinone derivativesPLETTENBURG OLIVER·Filed 2009·Granted Apr 29, 2014·0 cites·47 claims
- 2549US2013109715A16-Substituted isoquinolines and isoquinolinonesPLETTENBURG OLIVER·Filed 2012·Application pending·0 cites
- 2644US9776991B2Thienomethylpiperazine derivatives as inhibitors of soluble epoxide hydrolaseSANOFI SA·Filed 2014·Granted Oct 3, 2017·0 cites·2 claims
- 2743US9598410B2Substituted 4,5,6,7-tetrahydro-1H-pyrazolo[4,3-C]pyridines, their use as medicament, and pharmaceutical preparations comprising themSANOFI SA·Filed 2015·Granted Mar 21, 2017·0 cites·11 claims
- 2841US10806797B2Prodrugs comprising an GLP-1/glucagon dual agonist linker hyaluronic acid conjugateSANOFI SA·Filed 2016·Granted Oct 20, 2020·0 cites·28 claims
- 2940US9540391B2Isomannide derivatives as inhibitors of soluble epoxide hydrolaseSANOFI SA·Filed 2014·Granted Jan 10, 2017·0 cites·8 claims
Join the waitlist — get patent alerts
Get an alert when Katrin Lorenz files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →